Japan Tissue Engineering Co., Ltd. (TYO:7774)
786.00
+4.00 (0.51%)
Aug 6, 2026, 11:30 AM JST
Japan Tissue Engineering Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 3,347 | 3,250 | 3,885 | 4,266 | 4,134 | 4,933 |
Cash & Short-Term Investments | 3,347 | 3,250 | 3,885 | 4,266 | 4,134 | 4,933 |
Cash Growth | -14.64% | -16.35% | -8.93% | 3.19% | -16.20% | -6.48% |
Receivables | 661.21 | 546 | 594 | 608 | 576 | 496 |
Inventory | 243.71 | 235 | 181 | 228 | 237 | 187 |
Prepaid Expenses | - | 28 | 30 | 32 | 21 | 18 |
Other Current Assets | 173.2 | 123 | 134 | 205 | 243 | 311 |
Total Current Assets | 4,425 | 4,182 | 4,824 | 5,339 | 5,211 | 5,945 |
Property, Plant & Equipment | 1,318 | 1,336 | 1,420 | 1,510 | 1,567 | 1,613 |
Long-Term Investments | 113.25 | 114 | 171 | 36 | 10 | 2 |
Other Intangible Assets | 51.68 | 50 | 96 | 102 | 93 | 36 |
Other Long-Term Assets | 0 | - | 1 | 1 | 2 | 2 |
Total Assets | 5,909 | 5,682 | 6,512 | 6,988 | 6,883 | 7,598 |
Accounts Payable | 46.44 | 107 | 109 | 84 | 136 | 117 |
Accrued Expenses | 60.45 | 143 | 151 | 180 | 151 | 151 |
Current Income Taxes Payable | 21.68 | 190 | 208 | 245 | 337 | 301 |
Other Current Liabilities | 605.29 | 120 | 169 | 364 | 287 | 327 |
Total Current Liabilities | 733.86 | 560 | 637 | 873 | 911 | 896 |
Pension & Post-Retirement Benefits | 32.2 | 32 | 50 | 34 | 34 | 34 |
Other Long-Term Liabilities | 0 | - | - | 1 | 1 | 2 |
Total Liabilities | 766.06 | 592 | 687 | 908 | 946 | 932 |
Common Stock | 3,998 | 3,997 | 4,958 | 4,958 | 4,958 | 4,958 |
Additional Paid-In Capital | 1,828 | 1,827 | 2,788 | 2,788 | 2,788 | 2,788 |
Retained Earnings | -682.51 | -734 | -1,922 | -1,666 | -1,810 | -1,080 |
Comprehensive Income & Other | -0 | - | 1 | - | 1 | - |
Shareholders' Equity | 5,143 | 5,090 | 5,825 | 6,080 | 5,937 | 6,666 |
Total Liabilities & Equity | 5,909 | 5,682 | 6,512 | 6,988 | 6,883 | 7,598 |
Net Cash (Debt) | 3,347 | 3,250 | 3,885 | 4,266 | 4,134 | 4,933 |
Net Cash Growth | -14.64% | -16.35% | -8.93% | 3.19% | -16.20% | -6.48% |
Net Cash Per Share | 82.42 | 80.03 | 95.67 | 105.05 | 101.80 | 121.47 |
Filing Date Shares Outstanding | 40.61 | 40.61 | 40.61 | 40.61 | 40.61 | 40.61 |
Total Common Shares Outstanding | 40.61 | 40.61 | 40.61 | 40.61 | 40.61 | 40.61 |
Working Capital | 3,692 | 3,622 | 4,187 | 4,466 | 4,300 | 5,049 |
Book Value Per Share | 126.63 | 125.34 | 143.44 | 149.72 | 146.20 | 164.15 |
Tangible Book Value | 5,091 | 5,040 | 5,729 | 5,978 | 5,844 | 6,630 |
Tangible Book Value Per Share | 125.36 | 124.11 | 141.07 | 147.21 | 143.91 | 163.26 |
Order Backlog | - | 374 | 245 | 401 | 224 | 184 |